Currently, there is little evidence for a significant impact of the vertebrate microRNA
(miRNA) system upon the pathogenesis of RNA viruses
1
. This is primarily attributed to the ease with which these viruses mutate to disrupt
recognition and growth suppression by host miRNAs
2,3
. Here, we report that the hematopoietic cell-specific miRNA, miR-142-3p, potently
restricts the replication of the mosquito-borne North American (NA) eastern equine
encephalitis virus (EEEV) in myeloid-lineage cells by binding to sites in the 3′ non-translated
region (NTR) of its RNA genome. However, by limiting myeloid cell tropism and consequent
innate immunity induction, this restriction directly promotes neurologic disease manifestations
characteristic of EEEV infection in humans. Furthermore, the region containing the
miR-142-3p binding sites is essential for efficient virus infection of mosquito vectors.
We propose that RNA viruses can adapt to utilize antiviral properties of vertebrate
miRNAs to limit replication in particular cell-types and that this restriction can
lead to exacerbation of disease severity.
miRNAs are 21-23 nucleotide host-encoded RNAs that are cell-specific and bind to complementary
sequences in the 3′ NTR of host mRNAs
4
. The extent of sequence complementary between the miRNA and mRNA leads to control
of mRNA-encoded polypeptide levels by either a block in translation, degradation of
the mRNA, or both
5,6
. For RNA viruses, limited evidence exists for host miRNAs binding to viral RNAs and
restricting infection or affecting disease
1,7,8
. In the case of hepatitis C virus (HCV), the opposite is observed: the liver-specific
miRNA, miR-122, binds to the viral 5′ NTR, stabilizing the RNA and enhancing in vitro
viral replication
9,10
.
Wild-type (WT) NA EEEV strains are highly virulent mosquito-borne alphaviruses causing
a 30-70% case fatality rate in humans
11
. The recognized geographic range and disease incidence of EEEV in the northeastern
United States has increased over the past 10 years raising concern about potential
widespread outbreaks
12
. EEEV disease is characterized by a limited prodrome prior to manifestations of encephalitis,
resulting from restricted myeloid cell replication and minimal induction of systemic
type I interferon (IFN)
13,14
. Longer prodromes in human pediatric cases increased the likelihood of recovery,
suggesting that host prodromal responses may limit disease severity
15
.
WT EEEV is defective for replication in human and murine macrophages and dendritic
cells
13
. Using a luciferase-expressing translation reporter RNA encoding the 5′ and 3′ NTRs
and translation initiation control sequences of WT EEEV (Extended Data Fig. 1a), we
found that translation was restricted in murine RAW 264.7 (RAW) cells, a monocyte/macrophage
myeloid cell line, versus BHK-21 fibroblasts (Fig.1a and Extended Data Fig 1d)
13
. Translation of an analogous reporter RNA derived from the related myeloid cell-tropic
WT Venezuelan equine encephalitis virus (VEEV) was efficient in both RAW (Fig. 1a)
and BHK-21 cells (Extended Data Fig 2a,b)
13,16
. Removal of the EEEV 5′ NTR(EEEV 5′Δ NTR; Extended Data Fig.1b) did not alleviate
the restriction in translation in RAW cells (Fig.1a), suggesting the EEEV 3′ NTR confers
this restriction. Indeed, transfer of the EEEV 3′ NTR to a host mRNA mimic(5′ host
3′ EEEV; Extended Data Fig. 1c) resulted in translation blockade in RAW cells but
not in BHK-21 cells (Fig.1a, and Extended Data Fig 1d). Transfer of the VEEV 3′ NTR
to the host mimic had no effect on translation in RAW or BHK-21 cells (Extended Data
Fig. 2a, b). Therefore, the EEEV 3′ NTR but not VEEV 3′ NTR contains the restricting
element(s).
Two miRNA prediction algorithms, miRANDA
17
and PITA
18
, identified three putative canonical and one non-canonical binding sites for the
hematopoietic cell-specific miRNA, miR-142-3p, in the 3′ NTR of the NAEEEV strain
FL93-939 (Extended Data Fig.3a,b). The three canonical miR-142-3p seed sites are conserved
in 17 of 23 sequenced NA EEEV strains collected between 1954 and 2012, suggesting
a strong selection for their retention
19
(S. Weaver unpublished data). To determine whether the miR-142-3p binding sites in
the EEEV 3′ NTR restrict viral replication, we generated an EEEV mutant (11337) with
a deletion of 260 nucleotides encompassing all of the miR-142-3p binding sites (Extended
Data Fig.3c). In BHK-21 cells, we observed no significant difference in viral replication
at 12 hours post-infection (h.p.i.) with 11337 compared to WT EEEV (P > 0.2, Extended
Data Fig 3d). However, replication of 11337 in RAW cells (Fig. 1b) was nearly 1000-fold
higher than WT EEEV within 8 h.p.i.. A similar phenotype was observed after infection
of human K562 and THP-1 monocyte/macrophage cells with WT EEEV and 11337 (Extended
Data Fig. 4a, b) as well as primary bone marrow-derived dendritic cells (BMDCs) reported
to express high levels of miR-142-3p
20
(Fig. 1c). WT EEEV remained replication-defective in BMDCs in the absence of type
I IFN signaling (Extended Data Fig. 4c)
13
, however, replication of 11337 increased, indicating that myeloid cell restriction
of WT EEEV is IFN-independent but dependent upon the 3′ NTR sequences containing the
miR-142-3p binding sites. All monocyte/macrophage cells used in this study expressed
high levels of miR-142-3p in contrast to BHK-21 cells, in which miR-142-3p expression
was undetectable (Extended Data Fig. 5).
To confirm a specific role for miR-142-3p in restricting EEEV replication, we expressed
miR-142 in BHK-21 cells and assessed its effects on infection by WT EEEV, 11337, and
WT VEEV. Ectopic expression of miR-142 in BHK-21 cells (Extended Data Fig. 5) completely
blocked WT EEEV infection in comparison to control cells expressing a neuron-specific
miRNA, miR-124 (Fig.1d)
21
. In contrast, both 11337 and WT VEEV infected miR-142-expressing BHK-21 cells. To
demonstrate the dependence of this restriction on the specific miR-142-3p binding
sites, we generated mutant viruses that either had each of the miR-142-3p binding
sequences deleted (142del) or three point mutations in each miR-142-3p binding site
seed sequence (142pm; Extended Data Fig. 6a,b). These viruses replicated equally well
in BHK-21 (Extended Data Fig. 6c) and RAW cells (Fig. 1e) similar to 11337. To confirm
the increase in replication in myeloid cells was due to translation of the viral genome,
we infected RAW cells with nsP3 reporter viruses to measure translation of virus-particle
delivered genomes
13
. Translation was significantly increased by 4 h.p.i. with 142del and 142pm viruses
compared to WT EEEV (Fig 1f). Finally, we infected BMDCs derived from miR-142-deficient
(miR-142-/-) mice
20
with WT EEEV or 11337, and detected no significant difference in viral titers between
the viruses after 12 h.p.i.(P > 0.1, Fig.1g). These data demonstrate that the presence
of hematopoietic cell-specific miR-142-3p binding sites in the WT EEEV 3′ NTR results
in potent blockade of viral translation and subsequent replication in miR-142-3p-expressing
cells in vitro.
WT EEEV-infected mice exhibit a minimal prodrome (e.g., ruffled fur, hunched posture,
weight loss), which is likely due to restricted myeloid cell replication and minimal
type I IFN induction
13, 14
. To assess the contribution of the miR-142-3p binding sites in EEEV to this phenotype,
we infected CD-1 mice with WT EEEV and 11337. Survival times were extended in 11337-infected
mice compared to WT-infected mice (Fig.2a) with evidence of prodromal disease developing
only in 11337-infected mice (Fig.2b). WT EEEV naturally binds heparan sulfate (HS),
which limits viral dissemination while also increasing neurovirulence
14
. Therefore, we included a HS binding-defective EEEV mutant (71-77) for a comparison
with WT VEEV, which does not bind HS efficiently
14,22
. The 71-77 mutant was significantly attenuated compared to WT EEEV, and elicited
signs of prodrome similar to 11337, suggesting that both HS binding and miRNA restriction
contribute to the inhibition of prodromal disease. Combining the HS binding-defective
mutation with the 11337 deletion (71-77/11337) increased both survival times and prodromal
signs compared to WT EEEV or 11337 infection. The timing of prodrome onset following
71-77/11337 infection was only slightly delayed compared to WT VEEV – infected mice
(Fig.2b). Consistent with limited prodrome, systemic type I IFN induction is rarely
detected during WT EEEV infection (Fig.2c)
13
. However, IFN-α/β was detected by 12 h.p.i. in sera from 11337-infected mice, similar
to mice infected with the HS binding mutant 71-77, and both were significantly higher
than WT EEEV. Infection with 71-77/11337 elicited higher levels of IFN-α/β within
8 h.p.i. compared to WT EEEV, and induced at 12 h.p.i., IFN-α/β levels similar to
those in sera from WT VEEV-infected mice. These results are consistent with a study
in which the addition of artificial miR-142-3p binding sites into the genome of influenza
virus reduced IFN-α/β induction in vivo, suggesting that myeloid cell replication
may be necessary for serum IFN-α/β induction with multiple viruses
23
.
Previously, we observed that serum levels of IFN-α/β and prodromal signs were associated
with alphavirus replication in myeloid cells within popliteal lymph nodes (PLN) after
footpad inoculation
13, 14
. While WT EEEV replicated poorly in the PLN compared to WT VEEV throughout infection
(Fig.2d), both 71-77 and 11337 viruses replicated significantly more than WT EEEV
by 12 h.p.i.. The double mutant, 71-77/11337, replicated more efficiently in PLNs
at all time points compared to either 71-77 or 11337, and at levels comparable to,
but lower than those seen in WT VEEV-infected PLNs. Replication restriction was alleviated
for 71-77 and 71-77/11337 in type I IFN receptor-deficient IFNAR1-/- mice (Fig.2d),
and survival times for the four viruses were essentially identical (P > 0.1; Extended
Data Fig. 7) indicating that IFN-α/β is the primary attenuating factor for 11337 and
71-77/11337, and that the 11337 mutation does not compromise replication in vivo in
comparison with the WT virus. Fluorescence microscopy and flow cytometric analysis
(FCA) of PLNs from mice infected with mCherry-expressing viruses demonstrated the
number of cells infected after WT EEEV infection were not significantly different
from uninfected mice, but 11337 and 71-77/11337 infected a significantly higher number
of cells compared to WT EEEV, with the number of cells infected with 71-77/11337 approaching
those seen after WT VEEV infection (Fig. 2e,f). Cells infected by 11337, 71-77/11337
and WT VEEV were predominantly CD11b+ with a subset also CD11c+ indicative of myeloid
lineage cells (Extended Data Fig. 8). 71-77 appeared to infect some PLN cells by microscopy
(Fig. 2e), however failure to detect 71-77 PLN infection by FCA (Fig. 2f) is consistent
with the presence of miR-142-3p binding sites in the 3′ NTR of this virus. Overall,
deletion of the miR-142-3p binding sites alone or in combination with disruption of
the HS-binding ability of EEEV increased infection of PLN myeloid-lineage cells, prodromal
disease signs, and type I IFN production but decreased virulence in vivo dependent
upon a functioning IFN-α/β response.
Given the rapid mutation rate of RNA viruses we hypothesized that the miR-142-3p binding
sites in the EEEV 3′ NTR are maintained through positive selection during the mosquito-vertebrate
transmission cycle. In C6/36 mosquito cells, the replication of 11337, 142del, and
142pm viruses was significantly reduced compared to WT EEEV at 12 h.p.i (Fig. 3a);
however by 24 h.p.i, only the 11337 and 142del viruses remained attenuated. Furthermore,
reduced infection rates of the EEEV bridge vector, Aedes (Ochlerotatus) taeniorhynchus
24
, via artificial blood meals were observed for 11337, 142del, and 142pm viruses compared
to WT EEEV (Fig. 3b). Therefore, specific sequences of the miR-142-3p binding sites
are required for efficient mosquito infection.
We have demonstrated that host miRNA restriction of EEEV replication in myeloid cells
is a novel mechanism that determines virus tropism for this cell lineage. Moreover,
at least portions of these NTR sequences promote mosquito vector infection, suggesting
positive selection as a mechanism for binding site retention during natural EEEV transmission.
It is also clear from these data that, at the organism level, miRNA-mediated restriction
of virus replication can lead to suppression of innate immune responses and exacerbation
of disease, thereby benefiting the infecting microorganism. Understanding the role
of miRNA expression levels and virus genotype in the efficiency of restriction may
give insight into temporal, geographical and individual host variation in EEE and
potentially other RNA virus diseases.
Materials and Methods Summary
Culture of baby hamster kidney cells (BHK-21), L929 fibroblasts and RAW 264.7 (RAW)
monocyte/macrophage cells and bone-marrow derived dendritic cells (BMDCs) from CD-1,
IFNAR1-/- and miR-142-/- mice has been described
13,20
. Virus growth curves with BHK-21 cell titration of progeny viruses were performed
as described previously
13
using eGFP or mCherry-reporter viruses described below.
WT EEEV, WT VEEV and host mimic luciferase-expressing translation reporters were described
previously
25,26
. Other reporters were constructed using the QuikChange II XL mutagenesis kit. Translation
assays were performed as described with minor modifications
13
.
Construction of cDNA clones of VEEV ZPC 738
27
(WT VEEV), EEEV FL93-939
28
(WT EEEV) and EEEV 71-77
14
were described previously. The EEEV 11337, 142del and 142pm mutants were constructed
from the FL93-939 cDNA. mCherry-, eGFP-, and Nano-Luciferase (nLuc)-expressing versions
of all viruses were constructed similarly to a described capsid-PE2 fusion reporter
viruses using the QuikChange II XL kit
29
.
The eGFP-expressing pCMV-miR-142 or pCMV-miR-124, expression plasmids were electroporated
into BHK-21 cells. After ∼18 hours, cells were infected with mCherry-reporter viruses
for 8 hours followed by assessment of co-expression of the miRNA (eGFP), and virus
reporter (mCherry) using fluorescence microscopy.
Outbred CD-1 mice were infected subcutaneously and evaluated for morbidity and mortality
as described
13,14
. For tissues, CD-1 or IFNAR1-/- mice were infected with nLuc- or mCherry-reporter
viruses. PLNs were harvested at indicated time points and processed for Nano-Glo luciferase
assay, for fluorescence microscopy, or for FCA of virus-infected cells. Serum IFN-α/β
was measured using a standard biological assay as described
13
.
Adult female A. taeniorhynchus mosquitoes were infected with EEEV viruses in artificial
blood meals. Engorged females were incubated 10 days and assayed for infection by
infection of Vero cells and observation for cytopathic effects
30
.
Methods
Cell Culture
Baby hamster kidney cells (BHK-21), L929 fibroblasts, and RAW 264.7 (RAW) macrophage-monocyte
cells were maintained as described previously
13
. Bone marrow-derived dendritic cells (BMDCs) from CD-1, IFNAR1-/- and miR-142-/-
mice
20
were generated and maintained as previously described
13
. However, miR-142-/- bone marrow was harvested and frozen in 10% DMSO and 90% fetal
bovine serum (FBS) prior to culture. Aedes albopictus C6/36 mosquito cells were maintained
in minimum essential medium alpha medium (Cellgro) supplemented with 10% FBS and 1%
L-Glutamine (Gibco).
Translation Reporters and Dual Luciferase Assay
WT EEEV, WT VEEV and host mimic luciferase-expressing translation reporters (diagram
in Extended Data Fig. 1) were generated previously
25,26
. The host mimic translation reporters encode a short 5′ and 3′ NTR fused in frame
with the fLuc gene. The EEEV 5′Δ NTR and VEEV 5′Δ NTR reporters were constructed using
QuikChange II XL mutagenesis kit (Agilent Technologies, Santa Clara, CA) and the primers
listed in Extended Data Table 1. The chimeric 5′ host 3′ EEEV and 5′ host 3′ VEEV
translation reporter was constructed by addition of a restriction endonucleases site
into the host fLuc mimic reporter using QuikChange II XL mutagenesis and the primers
listed in Extended Data Table 1. The 3′ NTR of EEEV or VEEV was then placed into the
host fLuc mimic after the fLuc gene with endonuclease digestion. Translation assays
were performed as described previously with modifications
13
. Each in vitro transcribed reporter RNA (7.5 μg/reaction) and the Renilla reporter
RNA (0.75 μg/reaction) were electroporated into RAW and BHK-21 cells (6 × 106 cells/reaction)
using the Neon Transfection system (Invitrogen; BHK-21: 1200 V, 30 ms, 1 pulse. RAW:
1750 V, 25 ms, 1 pulse). Two reactions were combined and aliquoted in triplicate per
time point per experiment. Firefly relative light units (RLU) data were normalized
to Renilla RLUs in each sample.
Viruses
Construction of cDNA clones of VEEV ZPC 738
27
(WT VEEV), EEEV FL93-939
28
(WT EEEV) and EEEV 71-77
14
were previously described. mCherry, eGFP, and Nano-Luciferase (nLuc) reporter viruses
were constructed as a cleavable in-frame fusion between the capsid and E3 proteins
using QuikChange II XL mutagenesis kit with the first 5 amino acids of E3 fused in-frame
to the amino terminus of the reporter genes and the 2A-like protease of Thosea asigna
virus (TaV) fused to the carboxy terminus (C.S., C.L.G., K.D.R. W.B.K. manuscript
in preparation)
29
. The EEEV 11337, 142del and 142pm mutants were generated using the EEEV FL93-939
cDNA clone and QuikChange mutagenesis II XL kit and primers listed in Extended Data
Table 2. WT EEEV nsP3-nLuc translation reporter virus was constructed with the nLuc
gene fused in frame with nsP3 (C.S., C.L.G., K.D.R. W.B.K. manuscript in preparation)
13
. The 3′ NTR of each mutant was placed into TaV and nsP3-nLuc reporter viruses using
EcoRI and Not I.
Virus Infections and Plaque Assay
Virus growth curves were performed as described previously using eGFP or mCherry reporter
viruses described above
13
. Briefly, BHK-21, RAW and C6/36 cells (2 × 105 cells/well) were infected in triplicate
in 24 well plates at a multiplicity of infection (MOI) of 0.1 plaque forming units
(PFU)/cell or 1 PFU/cell(C6/36). BMDCs (1 × 105 cells) were infected in triplicate
at an MOI of 5 PFU/cell in suspension, washed and transferred into 24 well plates.
For growth curves, supernatant was harvested at time zero and indicated time points
for titration by plaque assay on BHK-21 cells. For nsP3 translation reporter assays,
RAW (4 × 105 cells/well) were infected at an MOI of 1 PFU/cell in triplicate with
nsP3-nLuc reporter viruses and harvested at indicated time points using 1× Passive
Lysis Buffer (PLB; Promega). nLuc expression was quantified using the Nano-Glo Luciferase
assay system (Promega) according to manufacturer's guidelines and normalized to protein
concentration using a Pierce BCA protein assay (Thermo Scientific, Rockford, IL).
miRNA overexpression
The pCMV-miR-142 expression plasmid and a neuron-specific miRNA, pCMV-miR-124, (OriGene,
Rockville, MD) were electroporated (4 μg each) into BHK-21 cells (1 × 106 cells) using
the Amaxa Nucelofector Kit L (Lonza, Basel, Switzerland) according to manufacturers
guidelines. After ∼18 hours, cells were infected with WT EEEV, WT VEEV or EEEV 11337
mCherry TaV viruses (MOI = 1 PFU/cell) for 8 hours followed by fixation. Co-expression
of the miRNA (eGFP), and virus reporter (mCherry) was determined using fluorescence
microscopy as previously described
13
. Data is represented as the ratio of the percentage of cells co-expressing the microRNA,
miR-142, (eGFP) and virus-infected (mCherry) to cells co-expressing miR-124 and virus-infected.
RT-PCR to detect miR-142-3p
Total cellular RNA was harvested from cells using Trizol (Life Technologies) and 1-bromo-3-chloropropane
(BCP) and isopropanol. RNA (200 ng) was reverse transcribed with the miScript II RT
kit (Qiagen, Germantown MD) according to manufacturers' guidelines. cDNA was diluted
in water and mature miR-142-3p was quantified using the miScript SYBR Green PCR kit
(Qiagen) according to manufacturers' guidelines using the miR-142-3p specific primer
5′-TGTAGTGTTTCCTACTTTATGGA-3′. miR-142-3p expression was normalized to RNU6B using
the primer 5′-GATGACACGCAAATTCGTGAA-3′ and the ΔΔCT method. Data is calculated as
fold change in expression compared to expression of miR-142-3p in BHK-21 cells in
which miR-142-3p expression was undetected.
Mouse infections, Tissue Harvest, nLuc Analysis
Six-week old female outbred CD-1 mice (Charles River Laboratories) and 6-9 week old
female or male IFNAR1-/- mice bred in house were randomly distributed, infected subcutaneously
(sc) in both footpads and scored daily for clinical signs and weight loss as described
previously
13, 14
. Two investigators were used to analyze the clinical symptoms observed in the mice
during morbidity and mortality studies. Investigators were not privy to timing and
onset of clinical symptoms from previous experiment. For tissue harvest, mice were
infected with 103 PFU of nLuc- or mCherry-reporter TaV viruses. Popliteal lymph nodes
(PLN) were harvested at indicated time points and either frozen on dry ice, placed
in 200 μl 1× PLB for nLuc analysis or placed in 4% paraformaldehyde (PFA) for one
week for visualization on a fluorescence microscope. PLN were homogenized and analyzed
for nLuc expression using the Nano-Glo Luciferase assay system. All EEEV PLN were
photographed using equal exposure times (615 ms) while the VEEV LN, due to an increased
signal, was visualized using a lower exposure time (90 ms) at 4× magnification using
cellSens Standard software (Olympus). The 71-77/11337 inset was imaged at 40× magnification
and 457 ms exposure length. Brightness and contrast of the images were adjusted equally
using Adobe Photoshop CS3 and Microsoft Powerpoint software. All animal procedures
were carried out in accordance with American Association for the Accreditation of
Laboratory Animal Care International-approved institutional guidelines for animal
care and use and approved by the University of Pittsburgh Institutional Animal Care
and Use Committee. No statistical methods were used to ensure adequate power. Sample
sizes were chosen based upon experience with the mortality kinetics of EEEV in mice
and historical group number requirements to achieve statistical significance yet utilize
the fewest animals possible.
Quantification of virus-infected cells from PLN
To quantify number of virus infected cells in PLN, CD-1 mice were infected as above,
and PLNs were harvested 12 h.p.i., minced, and incubated with Liberase TL (0.2 mg/ml;
Roche) and DNaseI (0.2 mg/ml; Roche) for 20 min at 37°C. After removal of cellular
debris, cells were stained with anti-mouse CD16/32 (93; eBioscience), and Fixable
Viability Dye eFluor 506 (eBioscience). After washing, cells were stained with anti-mouse
CD11b (clone N418, Tonbo Biosciences, San Diego, CA), and anti-mouse CD11c (M1/70;
eBioscience) to identify myeloid cells. Cells were fixed in 4% PFA and analyzed using
a BD LSRFortessa (BD Bioscience) and FloJo Software (Tree Star Inc., Ashland, OR).
Number of virus-infected cells was calculated based on total number of cells in both
PLNs per mouse.
IFN-α/β Analysis
Serum IFN-α/β was measured using a standard biological assay on L929 cells as described
previously
13
.
Mosquito Infection
Adult female Aedes (Ochlerotatus) taeniorhynchus mosquitoes were infected with EEEV,
11337, 142del and 142pm mCherry- or eGFP-reporter TaV viruses in artificial bloodmeals.
Engorged females were incubated at 27°C for 10 days under 12 hour light/12 hour dark
circadian lighting conditions and assayed for infection by inoculation onto Vero cell
monolayers and observation for cytopathic effects as described previously
30
.
Statistical Analysis
Statistical significance for mortality curves was determined by Mantel-Cox log-rank
test. For all viral growth curve experiments, data was log10 transformed and unpaired
t tests were performed and corrected for multiple comparisons using the Holm-Sidak
method with an alpha = 0.05. For all other experiments, a two-tailed unpaired t test
was used (GraphPad Prism software). Statistical analysis for nLuc expression in CD-1
PLN was performed comparing WT EEEV versus the other EEE viruses while WT VEEV was
compared to only 71-77/11337 at each time point. nLuc expression in IFNAR1-/- mice
was compared to the corresponding viruses at 12 h.p.i. in CD-1 mice only. Statistical
analysis for quantification of the number of infected cells in PLN was performed between
the EEEV mutant viruses and WT EEEV, and between WT VEEV and 71-77/11337.
Extended Data
Extended Data Figure 1
EEEV 3′ NTR does not restrict translation in BHK-21 fibroblasts
a. WT EEEV and WT VEEV translation reporters encode the translational initiation control
sequences fused to the fLuc gene. b. The EEEV 5′ Δ NTR and VEEV 5′ Δ NTR encode the
truncated nsP1 gene and only the 3′ NTR of either EEEV or VEEV. c. The 3′ NTR of EEEV
or VEEV was inserted into a host mRNA mimic reporter to generate the 5′ host 3′ EEEV
or 5′ host 3′ VEEV reporters. All translation reporters contain a 5′ cap and a 3′
poly (A) tail. d. Translation of WT EEEV, EEEV 5′ Δ NTR, and 5′ host 3′ EEEV reporters
in BHK-21 cells. Error bars represent mean ± S.D. and the data are averaged from three
independent experiments performed in triplicate.
Extended Data Figure 2
VEEV 3′ NTR does not restrict translation in myeloid cells
Translation of WT VEEV, VEEV 5′ Δ NTR, and 5′ host 3′ VEEV reporters in RAW (a) and
BHK-21 (b) cells. Error bars represent mean ± S.D. and the data are averaged from
three independent experiments performed in triplicate.
Extended Data Figure 3
Removal of miR-142-3p binding sites in the 3′NTR of EEEV does not alter replication
in BHK-21 fibroblasts
a. Red boxes indicate the four miR-142-3p binding sites in the 3′ NTR. Numbers represent
nucleotide (nt) positions at the start and end of each miRNA binding site. b. Gray
boxes correspond to the complimentary nts in the EEEV 3′ NTR and miR-142-3p. c. EEEV
mutant 11337 contains a deletion in the 3′ NTR from nt 11337 to 11596. d. Replication
of WT EEEV and 11337 in BHK-21 cells. n = 3 independent experiments. Error bars indicate
geometric mean ± S.D., and asterisks indicate differences that are statistically significant
(**p<0.01).
Extended Data Figure 4
miR-142-3p binding sites in EEEV restrict replication in human macrophage/monocyte
cell lines and primary murine IFNAR-/- BMDCs
a-b. Replication of WT EEEV and 11337 in human K562 (a) and THP-1 (b) cells. n = 2
(THP-1) and 3 (K562) independent experiments. c. Removal of type I IFN does not alleviate
WT EEEV restriction in primary murine IFNAR-/- BMDCs. n = three independent experiments.
Data represent the geometric mean ± S.D., and asterisks indicate differences that
are statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001).
Extended Data Figure 5
Relative expression of miR-142-3p in mouse and human cells
Quantitative RT-PCR on primary murine BMDCs, murine and human monocyte/macrophage
cell lines, and BHK-21 cells expressing miR-142-3p (BHK-21 w/miR-142-3p). Fold increase
in expression is calculated compared to expression of miR-142-3p in BHK-21 cells in
which miR-142-3p expression was undetectable.
Extended Data Figure 6
Specific deletion of the miR-142-3p binding sites in the 3′ NTR of WT EEEV does not
alter replication in BHK-21 fibroblasts
a. EEEV 142del virus contains four deletions corresponding to the complimentary nucleotides
in the 3′ NTR that bind to miR-142-3p eliminating all four miR-142-3p binding sites.
b. EEEV 142pm virus contains three point mutations in each of the miR-142-3p binding
sites that correspond to the seed sequence of miR-142-3p. c. Replication of WT EEEV
and 11337 in BHK-21 cells. n = three independent experiments. Error bars indicate
geometric mean ± S.D.
Extended Data Figure 7
Type I IFN attenuates 11337 and 71-77/11337
Survival curves in IFNAR-/- mice. n = 8 and 10 (71-77/11337) mice per virus from two
independent experiments.
Extended Data Figure 8
EEEV 11337 and 71-77/11337 infect myeloid lineage cells in the PLN
a. Percent virus-infected cells in PLN in naïve, WT VEEV, WT EEEV, 71-77, 11337, and
71-77/11337 infected mice. Plots are representative of n = 4 (naïve), 5 (71-77), or
6 mice from two independent experiments. b-c. WT VEEV, 11337 and 71-77/11337 infect
myeloid lineage cells in the PLN. b. Representative flow plot frome 1 mice of CD11b
(y-axis) and CD11c (x-axis) expression on virus-infected cells. n = 4 (naïve), 5 (71-77)
or 6 mice from 2 independent experiments. c. Summary of CD11b and CD11c expression
on virus-infected cells from WT VEEV, 11337, and 71-77/11337 infected PLNs. Only mice
with responses above naïve mice background levels were used to determine CD11b and
CD11c expression.
Extended Data Table 1
Primers used to generate the translation reporters using the Quikchange II XL mutagenesis
kit
Reporter
Primer Name
Sequence
EEEV Δ5′ NTR
EEEV Δ5′ NTR-F
5′ –agctcggatcctaatacgactcactatagatggagaaagttcatgttgacttagacgca–3′
EEEV Δ5′ NTR-R
5′ –tgcgtctaagtcaacatgaactttctccatctatagtgagtcgtattaggatccgagct–3′
VEEV Δ5′ NTR
VEEV Δ5′ NTR-F
5′ –agaggatccctaatacgactcactatagatggagaaagttcacgttgacatcgaggaa–3′
VEEV Δ5′ NTR-R
5′ –ttcctcgatgtcaacgtgaactttctccatctatagtgagtcgtattagggatcctct–3′
Host mimic w/Not1
fLuc-Not1-F
5′ –cccaaaaaaaaaaaaaaaaaaaaaaaaaaaagcggccgccgtaatcatgtcatagc–3′
fLuc-Not1-R
5′ –gctatgacatgattacggcggccgcttttttttttttttttttttttttttttggg–3′
Extended Data Table 2
Primers used in the generation of EEEV mutant viruses
Virus
Primer Name
Sequence
11337
EEEV11337-F
5′ –gacattaacatcttgtcaaccggcagcgcataatgctgtcttttatatc–3′
EEEV11337-R
5′ –gatataaaagacagcattatgcgctgccggttgacaagatgttaatgtc–3′
142del
EEEV-Del-1-2-F
5′ –catagacattaacatcttgggcagtgtataaggcttcaccctagttcgatgtacttccg–3′
EEEV-Del-1-2-R
5′ –cggaagtacatcgaactagggtgaagccttatacactgcccaagatgttaatgtctatg–3′
EEEV-Del-3-4-F
5′ –ctttataatcaggcataattgggtaatataccgcctggcagcgcataatgctgtc–3′
EEEV-Del-3-4-R
5′ –gacagcattatgcgctgccaggcggtatattacccaattatgcctgattataaag–3′
142pm
ΔmiR-142-1-F
5′ –taacatcttgtcaaccacataactcaagaggcagtgta–3′
ΔmiR-142-1-R
5′ –attgtagaacagttggtgtattgagttctccgtcacat–3′
ΔmiR-142-2-F
5′ –taaggctgtcttactaaactcaagattcaccctag–3′
ΔmiR-142-2-R
5′ –ctagggtgaatcttgagtttagtaagacagcctta–3′
ΔmiR-142-3-F
5′ –gcataattgccgtatatacaattactcaagaggtaatataccgcctcttataaa–3′
ΔmiR-142-3-R
5′ –tttataagaggcggtatattacctcttgagtaattgtatatacggcaattatgc–3′
ΔmiR-142-4-F
5′ –ataccgcctcttataaactcaagaggcagcgc–3′
ΔmiR-142-4-R
5′ –gcgctgcctcttgagtttataagaggcggtat–3′